Lead Business Analyst
Vizient, Inc. | |
United States, Texas, Irving | |
290 East John Carpenter Freeway (Show on map) | |
Oct 10, 2026 | |
|
When you're the best, we're the best. We instill an environment where employees feel engaged, satisfied and able to contribute their unique skills and talents while living and working as their authentic selves. We provide extensive opportunities for personal and professional development, building both employee competence and organizational capability to fuel exceptional performance through an inclusive environment both now and in the future. Summary: In this role, you will lead complex healthcare revenue cycle analytics supporting client engagements focused on chargemaster optimization, pricing, reimbursement, claims, and financial performance. You will analyze large and complex datasets, develop analytical solutions, and translate findings into actionable recommendations. You will apply expertise in healthcare billing, reimbursement, and revenue cycle operations to identify opportunities, validate results, and deliver insights that support client and business decisions. Responsibilities:
Qualifications:
Estimated Hiring Range: At Vizient, we consider skills, experience, and organizational needs in our compensation approach. Geographic factors may adjust the range estimate and hires typically fall below the top range. Compensation decisions are tailored to individual circumstances. The current salary range for this role is $77,400.00 to $135,400.00.This position is also incentive eligible. Vizient has a comprehensive benefits plan! Please view our benefits here: http://www.vizientinc.com/about-us/careers Equal Opportunity Employer: Females/Minorities/Veterans/Individuals with Disabilities The Company is committed to equal employment opportunity to all employees and applicants without regard to race, religion, color, gender identity, ethnicity, age, national origin, sexual orientation, disability status, veteran status or any other category protected by applicable law. | |
Oct 10, 2026